MyChart Proxy Outreach to Parents (MyPOP) for Health Technology

(MyPOP Trial)

Recruiting at 3 trial locations

Overseen By Ada Fenick, MD

Age: 18+

Sex: Any

Trial Phase: Academic

Sponsor: Yale University

Disqualifiers: No MyChart, Proxy access activated

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: Unknown

5200 Participants Needed

Trial Summary

What is the purpose of this trial?

The goal of this randomized controlled trial is to assess the extent to which different modes of contacting parents who have not yet enabled to access to their children's medical records will result in greater proxy access. The main questions the study aims to answer are: * will outreach via text or patient portal message result in more parents having access than usual care (which is in-office suggestions to get access). * which mode - text or portal - will get more parents access. Participants will get a text message, or a portal message through their own patient portal, or no message. The investigators will check access to see which group has increased more during the study period.

Research Team

Ada Fenick, MD

Principal Investigator

Yale University

Eligibility Criteria

This trial is for parents or guardians of children aged 12 years or younger who have been seen at one of two health centers in the last three years. They must not already have proxy access to their child's electronic health records (EHR) and should not prefer contact by phone or physical letter.

Inclusion Criteria

I am the guardian of a child ≤12 years old who has been seen at a specified health center in the last 3 years.

Exclusion Criteria

Guardians with EHR proxy access already activated for all children in their care.

I prefer to be contacted by phone or letter as I don't use MyChart.

Treatment Details

Interventions

• MyChart Proxy Outreach to Parents (MyPOP)

Trial Overview The study is testing whether contacting parents through text messages, patient portal messages, or no message at all can increase their access to their children's medical records. It aims to find out which method is more effective: text messaging, portal messaging, or the usual in-office suggestions.

Participant Groups

Group I: Preferred Modality Experimental Treatment 2 Interventions

Text or email message to guardian with proxy information. If the guardian has no personal MyChart access, before sending proxy information to set up access to their child's MyChart, the investigators will message the guardian up to two times with information enabling them to access their personal MyChart.

Group II: Patient Portal Experimental Treatment 1 Intervention

Patient portal message (MyChart) to guardian with proxy information. If the guardian has no personal MyChart access, before sending proxy information to set up access to their child's MyChart, the investigators will message the guardian up to two times with information enabling them to access their personal MyChart.

Group III: Usual Care Active Control 1 Intervention

Care as usual

Who Is Running the Clinical Trial?

Yale University

Lead Sponsor

Trials

1,963

Recruited

3,046,000+